DexCom Inc (DXCM) Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
DexCom Inc (NASDAQ: DXCM) FY 2026 Other Release
19 articles, transcripts, and reports
DexCom Inc (NASDAQ: DXCM) FY 2026 Other Release
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Call dated Feb. 12, 2026 Corporate Participants: Sean Christensen — Vice President of...
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) FY 2026 Management Update
DexCom Inc (NASDAQ: DXCM) FY 2026 Corporate Conference
DexCom Inc (NASDAQ: DXCM) Sec Form 10K
DexCom Inc (NASDAQ: DXCM) Sec Form 8K
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Release
DexCom Inc (NASDAQ: DXCM) Q4 2025 Earnings Conference